You just read:

Non-Insulin Therapies for Diabetes Market 2016-2026: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors - Research and Markets

News provided by

Research and Markets

Aug 22, 2016, 07:15 ET